CAR-T cell therapy shows promise for rare autoimmune disorder in clinical trial.
TL;DR Summary
Cartesian Therapeutics' experimental CAR-T cell therapy shows promise in treating Myasthenia Gravis, a disease where the immune system attacks and destroys the junctions between nerves and muscles. A North Carolina forester suffering from the disease found hope in the treatment after struggling with leg and arm weakness.
Topics:health#car-t-cell-therapy#cartesian-therapeutics#experimental-treatment#healthcare#immune-system#myasthenia-gravis
- CAR-T cell therapy for myasthenia gravis shows promise in small study by Cartesian Therapeutics Endpoints News
- Potential treatment for rare autoimmune disorder adapted from CAR-T therapy National Institutes of Health (.gov)
- Cartesian maps the path for an autoimmune disease cell therapy Evaluate Pharma
- Potential treatment for rare autoimmune disorder could be adapted from CAR-T therapy, suggests clinical trial Medical Xpress
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
65%
134 → 47 words
Want the full story? Read the original article
Read on Endpoints News